Kumari Anita, Prajapati Himani
Department of Pharmacology, Dr YSP Govt Medical College, Nahan, Himachal Pradesh, India.
J Family Med Prim Care. 2025 May;14(5):2026-2030. doi: 10.4103/jfmpc.jfmpc_1869_24. Epub 2025 May 31.
Pharmacovigilance plays a vital role in patient safety by identifying, assessing, and preventing adverse drug reactions (ADRs). Despite its importance, pharmacovigilance awareness among healthcare professionals often remains limited, leading to underreporting of adverse drug reactions and compromising patient safety. Educational interventions offer a potential solution to enhance pharmacovigilance knowledge and a reporting practice.
To evaluate the effectiveness of an educational intervention in improving knowledge and ADR reporting behaviours among healthcare professionals.
A questionnaire-based pre- and post-intervention design was used, involving health care providers. This study was conducted in three sessions on different dates, with a stipulated time of 2 hour at a tertiary care hospital. Participants attended 2-hour educational session about awareness of pharmacovigilance knowledge, attitude, and practices. A 20-items questionnaire was used to assess about pharmacovigilance awareness before and after educational intervention.
Data were analysed using IBM SPSS 27 version software, employing a paired -test to measure changes in scores.
Post-intervention participants had a statistically significant increase in pharmacovigilance knowledge, improved attitude towards ADR reporting, and greater confidence in reporting practices. However, limitations such as the lack of a control group and short follow-up duration suggest that further research is needed to confirm long-term impacts.
Educational intervention is effective in enhancing Pharmacovigilance awareness among health care providers. Further studies should include a control group and longer follow-up to better understand the sustained impact of such an intervention. Integrated regular pharmacovigilance training within healthcare institutions and simplifying ADR reporting can further improve medication safety and patient outcomes.
药物警戒通过识别、评估和预防药物不良反应（ADR）在患者安全方面发挥着至关重要的作用。尽管其很重要，但医疗保健专业人员对药物警戒的认识往往仍然有限，导致药物不良反应报告不足，危及患者安全。教育干预为增强药物警戒知识和报告实践提供了一种潜在的解决方案。
评估教育干预对提高医疗保健专业人员知识水平和药物不良反应报告行为的有效性。
采用基于问卷的干预前和干预后设计，涉及医疗保健提供者。本研究在不同日期分三次进行，在一家三级护理医院规定时间为2小时。参与者参加了为期2小时的关于药物警戒知识、态度和实践认识的教育课程。使用一份20项的问卷来评估教育干预前后的药物警戒意识。
使用IBM SPSS 27版软件对数据进行分析，采用配对检验来测量得分变化。
干预后参与者在药物警戒知识方面有统计学上的显著增加，对药物不良反应报告的态度有所改善，并且在报告实践方面更有信心。然而，诸如缺乏对照组和随访时间短等局限性表明，需要进一步研究以确认长期影响。
教育干预在提高医疗保健提供者的药物警戒意识方面是有效的。进一步的研究应包括对照组和更长时间的随访，以更好地了解这种干预的持续影响。在医疗机构内开展综合定期的药物警戒培训并简化药物不良反应报告流程，可以进一步提高用药安全性和患者治疗效果。
